|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
IRCT |
|
Last refreshed on:
|
22 February 2018 |
|
Main ID: |
IRCT201201278832N1 |
|
Date of registration:
|
2012-12-19 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Evaluation of saffron effect on intraocular pressure in glaucoma patients
|
|
Scientific title:
|
The Ocular Hypotensive Effect of Saffron Extract in Primary Open Angle Glaucoma: a Pilot Study |
|
Date of first enrolment:
|
2012-02-22 |
|
Target sample size:
|
15 |
|
Recruitment status: |
Complete |
|
URL:
|
http://en.irct.ir/trial/9320 |
|
Study type:
|
interventional |
|
Study design:
|
Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment.
|
|
Phase:
|
2
|
|
|
Countries of recruitment
|
|
Iran (Islamic Republic of)
| | | | | | | |
|
Contacts
|
|
Name:
|
Mohammad Hossein Jabbarpoor Bonyadi
|
|
Address:
|
22 Bahman Hospital
Gonabad
Iran (Islamic Republic of) |
|
Telephone:
|
+98 53 3722 9012 |
|
Email:
|
drbonyadi@gmu.ac.ir |
|
Affiliation:
|
Gonabad University of Medical Sciences |
|
|
Name:
|
Mohammad Hossein Jabbarpoor Bonyadi
|
|
Address:
|
Gadir square Gonabad
Gonabad
Iran (Islamic Republic of) |
|
Telephone:
|
+98 53 3722 9012 |
|
Email:
|
drbonyadi@gmu.ac.ir |
|
Affiliation:
|
Gonabad University of Medical Sciences |
| |
|
Key inclusion & exclusion criteria
|
Inclusion criteria: inclusion criteria :open angle glaucoma; age >50
exclusioncriteria: angle closure glaucoma; systemic componding medication
Exclusion criteria:
Age minimum:
50 years
Age maximum:
no limit
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
primary open angle glaucoma.
Primary open-angle glaucoma
|
|
Primary open-angle glaucoma
|
|
Intervention(s)
|
|
saffron capsule daily( 30 mg)
|
|
placebo capsule daily
|
|
Intervention 1: placebo capsule daily. Intervention 2: saffron capsule daily( 30 mg).
|
|
Treatment - Drugs
|
|
Primary Outcome(s)
|
|
Intraocular pressure. Timepoint: baseline,7th,21th and 28th day after 1 month wash-out. Method of measurement: goldmann tonometery.
|
|
Source(s) of Monetary Support
|
|
Gonabad University of Medical Sciences
|
|
Ethics review
|
Status: Approved
Approval date:
Contact:
Ethics committee of Gonabad University of Medical Sciences
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|